HomeCompareEW vs WIT

EW vs WIT: Dividend Comparison 2026

EW yields 2.52% · WIT yields 5.59%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WIT wins by $11606.53M in total portfolio value
10 years
EW
EW
● Live price
2.52%
Share price
$79.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$295.93
Full EW calculator →
WIT
WIT
● Live price
5.59%
Share price
$2.07
Annual div
$0.12
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11606.55M
Annual income
$11,220,668,219.46
Full WIT calculator →

Portfolio growth — EW vs WIT

📍 WIT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEWWIT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EW + WIT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EW pays
WIT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EW
Annual income on $10K today (after 15% tax)
$213.84/yr
After 10yr DRIP, annual income (after tax)
$251.54/yr
WIT
Annual income on $10K today (after 15% tax)
$474.81/yr
After 10yr DRIP, annual income (after tax)
$9,537,567,986.54/yr
At 15% tax rate, WIT beats the other by $9,537,567,735.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EW + WIT for your $10,000?

EW: 50%WIT: 50%
100% WIT50/50100% EW
Portfolio after 10yr
$5803.29M
Annual income
$5,610,334,257.69/yr
Blended yield
96.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EW right now

EW
Analyst Ratings
32
Buy
16
Hold
Consensus: Buy
Price Target
$96.38
+21.2% upside vs current
Range: $87.00 — $110.00
Altman Z
10.9
Piotroski
5/9
WIT
Analyst Ratings
4
Buy
10
Hold
7
Sell
Consensus: Hold
Price Target
$7.35
+255.1% upside vs current
Range: $7.00 — $7.70
Altman Z
4.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EW buys
0
WIT buys
0
No recent congressional trades found for EW or WIT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEWWIT
Forward yield2.52%5.59%
Annual dividend / share$2.00$0.12
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%100%
Portfolio after 10y$23.4K$11606.55M
Annual income after 10y$295.93$11,220,668,219.46
Total dividends collected$2.8K$11579.69M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$96.38$7.35

Year-by-year: EW vs WIT ($10,000, DRIP)

YearEW PortfolioEW Income/yrWIT PortfolioWIT Income/yrGap
1← crossover$10,952$251.57$11,817$1,117.20$865.00WIT
2$11,976$257.49$15,112$2,467.69$3.1KWIT
3$13,077$263.14$22,069$5,898.58$9.0KWIT
4$14,261$268.55$39,714$16,100.60$25.5KWIT
5$15,533$273.70$96,651$54,157.39$81.1KWIT
6$16,899$278.61$349,776$246,359.23$332.9KWIT
7$18,365$283.28$2,040,731$1,666,470.39$2.02MWIT
8$19,938$287.72$20,357,117$18,173,535.39$20.34MWIT
9$21,626$291.93$360,638,911$338,856,795.79$360.62MWIT
10$23,436$295.93$11,606,551,855$11,220,668,219.46$11606.53MWIT

EW vs WIT: Complete Analysis 2026

EWHealthcare

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Full EW Calculator →

WITStock

Wipro Limited operates as information technology (IT), consulting, and business process services company worldwide. It operates through three segments: IT Services, IT Products, and India State Run Enterprise Services (ISRE). The IT Services segment offers IT and IT-enabled services, including digital strategy advisory, customer-centric design, technology and IT consulting, custom application design, development, re-engineering and maintenance, systems integration, package implementation, cloud and infrastructure, business process, cloud, mobility and analytics, research and development, and hardware and software design services to enterprises. It serves customers in various industry sectors, such as healthcare and medical devices, consumer goods and life sciences, retail, transportation and services, communications, media and information services, technology products and platforms, banking, financial services and insurance, manufacturing, hi-tech, energy, and utilities. The IT Products segment provides a range of third-party IT products comprising enterprise platforms, networking solutions, software and data storage products, contact center infrastructure, enterprise security, IT optimization technologies, video solutions, and end-user computing solutions. It serves enterprises in various industries primarily in the India market, which comprise the government, defense, IT and IT-enabled services, telecommunications, manufacturing, utilities, education, and financial services sectors. The ISRE segment offers IT services to entities and departments owned or controlled by the Government of India and/or various Indian State Governments. The company was incorporated in 1945 and is based in Bengaluru, India.

Full WIT Calculator →
📬

Get this EW vs WIT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EW vs SCHDEW vs JEPIEW vs OEW vs KOEW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.